24-desmethyl rifampicin B

Scale-up and commercialization of 24-desmethyl rifampicin effective against major first-line drug (rifampicin) resistant strains of Mycobacterium tuberculosis

  1. Work done under BIG-GRANT (BIRAC/KIIT0660/BIG-14/19). 
  2. Identifying Production Bottlenecks (Singhvi et al.2020, Singhvi et al. 2021, Sood et al. 2024. 
  3. Development of New Mutants.
!!Abstract Book!!   !!Poster Gallery!!  Scientific Program for the conference   Biosphere Journal: Submit Manuscript!!   Special offer on Lifetime Membership and INSCR 2021: Register Now
This is default text for notification bar
Learn more